Trial Profile
A Phase 2a double blind, randomised, placebo controlled, two dose study to determine the effect of orally administered methylnaltrexone (MNTX) in preventing post-operative opiate induced constipation in patients undergoing elective orthopaedic surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Norgine
- 31 Aug 2019 Status changed from recruiting to completed.
- 03 Nov 2014 New trial record